Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals 1 Year Total Returns (Daily) : 40.13% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 40.13% |
| August 20, 2026 | 40.57% |
| August 19, 2026 | 47.79% |
| August 18, 2026 | 41.89% |
| August 17, 2026 | 39.60% |
| August 14, 2026 | 42.73% |
| August 13, 2026 | 44.30% |
| August 12, 2026 | 44.15% |
| August 11, 2026 | 46.77% |
| August 10, 2026 | 44.30% |
| August 07, 2026 | 40.87% |
| August 06, 2026 | 39.84% |
| August 05, 2026 | 35.59% |
| August 04, 2026 | 33.81% |
| August 03, 2026 | 36.58% |
| July 31, 2026 | 40.57% |
| July 30, 2026 | 33.85% |
| July 29, 2026 | 25.27% |
| July 28, 2026 | 25.11% |
| July 27, 2026 | 19.12% |
| July 24, 2026 | 16.81% |
| July 23, 2026 | 14.51% |
| July 22, 2026 | 16.72% |
| July 21, 2026 | 24.43% |
| July 20, 2026 | 24.56% |
| Date | Value |
|---|---|
| July 17, 2026 | 23.70% |
| July 16, 2026 | 24.58% |
| July 15, 2026 | 21.91% |
| July 14, 2026 | 15.61% |
| July 13, 2026 | 17.42% |
| July 10, 2026 | 19.36% |
| July 09, 2026 | 21.53% |
| July 08, 2026 | 21.67% |
| July 07, 2026 | 26.34% |
| July 06, 2026 | 19.36% |
| July 02, 2026 | 20.09% |
| July 01, 2026 | 17.42% |
| June 30, 2026 | 19.41% |
| June 29, 2026 | 21.92% |
| June 26, 2026 | 22.13% |
| June 25, 2026 | 19.83% |
| June 24, 2026 | 20.01% |
| June 23, 2026 | 21.38% |
| June 22, 2026 | 20.81% |
| June 18, 2026 | 19.40% |
| June 17, 2026 | 20.11% |
| June 16, 2026 | 18.25% |
| June 15, 2026 | 16.83% |
| June 12, 2026 | 17.94% |
| June 11, 2026 | 18.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| Gilead Sciences, Inc. | 29.10% |
| AbbVie, Inc. | 30.40% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| Amgen, Inc. | 53.88% |